Efficacy of Romiplostim In the Treatment and Prevention of Recurrence of Persistent Chemotherapy-Induced Thrombocytopenia By Ogkologos - March 26, 2026 290 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the RECITE study Source RELATED ARTICLESMORE FROM AUTHOR Multicancer early detection test detects tumour-derived cfDNA and demonstrates robust performance characteristics with a favourable safety profile Anito-cel, a d-Domain BCMA CAR T-Cell, Induces Rapid, Deep, and Durable Responses in Patients with Heavily Pretreated Relapsed or Refractory Multiple Myeloma EMA Recommends Granting a Marketing Authorisation for Relacorilant MOST POPULAR Breast Cancer Patient Raising Money for 55 Women to Get Mammograms... December 4, 2020 How Can Occupational Therapy Assist with Chemotherapy-induced Peripheral Neuropathy? April 27, 2021 Rare Disease Day 2026: Advancing equity for people living with rare... February 27, 2026 Advancing Cancer Research as a Married Couple: “Your Stories” Podcast December 18, 2020 Load more HOT NEWS People With Certain Cancers Are Almost Three Times As Likely To... Metastatic Breast Cancer: ESMO Living Guideline Professor Eithne Costello: On the road to early detection Changes to chromosomes impact how children’s brain tumours respond to treatment
